Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
about
Involvement of autophagy in ovarian cancer: a working hypothesisDecorin causes autophagy in endothelial cells via Peg3The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathwaysDecorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cellsAutophagy in malignant transformation and cancer progressionEnvironmental Influences on Genomic ImprintingThe role and interaction of imprinted genes in human fetal growthOncogenic potential of yin yang 1 mediated through control of imprinted genesNanomaterials and autophagy: new insights in cancer treatmentPeg3 mutational effects on reproduction and placenta-specific gene familiesDiscovery of DNA methylation markers in cervical cancer using relaxation ranking.Epigenetic control of autophagy by microRNAs in ovarian cancerEpigenetic therapies for chemoresensitization of epithelial ovarian cancer.The biology of ovarian cancer: new opportunities for translationMolecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.S-phase cell cycle arrest, apoptosis, and molecular mechanisms of aplasia ras homolog member I-induced human ovarian cancer SKOV3 cell lines.JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHIDIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cellsAplasia Ras homologue member I overexpression induces apoptosis through inhibition of survival pathways in human hepatocellular carcinoma cells in culture and in xenograft.Regulation and function of the peg3 imprinted domain.Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft modelLoss of ARHI expression in colon cancer and its clinical significance.Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndromeEpigenetic regulation of cancer-associated genes in ovarian cancer.DNA methyltransferase candidate polymorphisms, imprinting methylation, and birth outcomeA high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.Clinically relevant microRNAs in ovarian cancerAberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancerEpigenomics and ovarian carcinoma.Small non-coding RNA deregulation in endometrial carcinogenesis.Special Agents Hunting Down Women Silent Killer: The Emerging Role of the p38α Kinase.DNA-Binding Motif of the Imprinted Transcription Factor PEG3.Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells.Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain.ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.Breast cancer risk and imprinting methylation in blood.Sex and Tissue Specificity of Peg3 Promoters.PEG3 Interacts with KAP1 through KRAB-A.
P2860
Q21198790-11477B2A-91D2-4FEB-9085-6F8A6379CE27Q24296756-92D195CC-7B34-4B34-ACFC-28467BD139A9Q24305947-5BC9ACEA-CE7C-48B8-B641-2EC33A326A66Q24323987-8B1C81CE-D27A-4DE6-867E-D560CFD2D251Q27000191-6234BF95-0580-4F3D-8089-80CD72E52BBEQ27015846-DB2473C7-78D8-4223-9EEC-59B1DB91CE36Q28083223-A000FBAF-1ACA-4BDF-B71D-DBC42B903AD4Q28257555-2D87B0AB-2700-4B5B-BCB3-997732F65438Q28386642-00458875-1434-4DD9-BCE7-020F83FB05D3Q28593550-7872B3B3-BB50-4F5C-9F4C-08986AAE76D9Q33386224-D152E51E-2DA5-446C-8017-5B3EB8CF1F5EQ33615837-4320C01D-B41D-4D48-AD23-E03913B66DABQ33621141-E7B73A7B-5758-4350-85CB-F783366ACAB0Q33622369-70AB01B2-C001-475C-950E-C084EF54FA15Q33628125-4F749AF7-B761-4E8D-A5B6-A9D715C07419Q33718135-63FDA246-5290-4363-A26D-E9EF71D999A4Q33830779-4EF98BAF-6AAA-4D8C-B11E-59054E04C6FAQ33878937-63A90C66-ABC8-464A-B0B1-116AE951DE35Q34217883-EEDC8DF3-0862-45C4-A775-5AA07FDC3961Q34335413-4C347B3B-4900-444C-8A1B-AC4DAD206180Q34429416-F99548D2-4651-41AA-9C1E-D4E7C743D629Q34589132-4BE9F91B-4D15-4C5F-B4F8-03F3D57D6F57Q34589981-936A342A-C236-4BBC-B0B1-89A81F848A62Q34638038-7197FF59-C36F-4EF2-B85A-C216A29E1F1DQ34874813-4BCC75B5-4E57-409F-B918-B73F88E1EC31Q34901834-9791CA4C-B18C-4D38-8EDA-E8DB19955C5CQ35025917-C2DB667C-9D18-4E0B-BEA0-357DCE2A8002Q35109281-33D37862-F93B-4993-819D-93C75B11851DQ35204609-5B30877A-2DBF-43F3-8017-90FF64479E44Q35624942-013C3263-5DB8-4783-8CAF-CFE0CE3DA94CQ35636575-44F6D24E-BEDF-4466-B89F-5493A5024026Q35741534-AED0FA01-BC46-4587-AA43-9B1271B6CCF1Q35864802-AEAB9F92-CAFC-4FB9-AAD3-6A1CDA365D3EQ35875028-09D542D0-BFFF-4E44-ABC1-F5D491F0C040Q35911242-56867157-77C0-49CD-AB67-E70FE574D4D7Q35996810-8D71C02C-992B-4D6F-BE06-CE8B73F302B3Q36022262-98004871-B15A-47CF-AF44-577598845095Q36027913-5EC42F21-60D7-430F-A0C0-72A4306E6DB9Q36154951-5F79013C-DCDF-4E0F-846A-31953219D8CBQ36206842-BEB540AA-9F07-4100-B245-FCDB78C16567
P2860
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Imprinted tumor suppressor gen ...... sity and promoter methylation.
@en
type
label
Imprinted tumor suppressor gen ...... sity and promoter methylation.
@en
prefLabel
Imprinted tumor suppressor gen ...... sity and promoter methylation.
@en
P2093
P356
P1433
P1476
Imprinted tumor suppressor gen ...... sity and promoter methylation.
@en
P2093
David M Fishman
Jean-Pierre J Issa
Jinsong Liu
Karen H Lu
Rebecca T Marquez
Weiwei Feng
P304
P356
10.1002/CNCR.23323
P407
P577
2008-04-01T00:00:00Z